OVARIAN EPITHELIAL CANCER RECURRENT

OVARIAN EPITHELIAL CANCER RECURRENT was reported 54 times

OVARIAN EPITHELIAL CANCER RECURRENT is most prevalent among patients taking these drugs:

# Drug Count Frequency
0 PAFOLACIANINE INJECTION 1 0.0159
1 TREOSULFAN 2 0.0007
2 MIRVETUXIMAB SORAVTANSINE 1 0.0006
3 NIRAPARIB 11 0.0005
4 DECITABINE 2 0.0005
5 TOPOTECAN HYDROCHLORIDE 1 0.0004
6 DOXORUBICIN HYDROCHLORIDE 8 0.0002
7 PACLITAXEL 23 0.0002
8 CARBOPLATIN 26 0.0002
9 OLAPARIB 4 0.0002
10 TOPOTECAN 1 0.0002
11 DOXORUBICIN 10 0.0001
12 IMATINIB MESYLATE 3 0.0001
13 CEFAZOLIN SODIUM 1 0.0001
14 BEVACIZUMAB 9 0.0001
15 FILGRASTIM 2 0.0001
16 FLUDARABINE PHOSPHATE 2 0.0001
17 PAZOPANIB HYDROCHLORIDE 1 0.0000
18 CYTARABINE 2 0.0000
19 VENETOCLAX 2 0.0000
20 ETOPOSIDE 2 0.0000
21 CISPLATIN 2 0.0000
22 GEMCITABINE HYDROCHLORIDE 1 0.0000
23 TACROLIMUS OINTMENT 0.1% 2 0.0000
24 TACROLIMUS EXTENDED-RELEASE CAPSULES 2 0.0000
25 TRASTUZUMAB 1 0.0000
26 TACROLIMUS 2 0.0000
27 TOCILIZUMAB 1 0.0000
28 METHOTREXATE SODIUM 2 0.0000